Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (66)

« Back to Publications

Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccination.

Watson RA. et al, (2024), J Immunother Cancer, 12

TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes.

Eyres M. et al, (2021), Gastroenterology, 161, 653 - 668.e16

The Potential of Artificial Intelligence to Detect Lymphovascular Invasion in Testicular Cancer.

Ghosh A. et al, (2021), Cancers (Basel), 13

Patient-derived malignant pleural mesothelioma cell cultures: a tool to advance biomarker-driven treatments.

Kanellakis NI. et al, (2020), Thorax, 75, 1004 - 1008

Detailed Molecular and Immune Marker Profiling of Archival Prostate Cancer Samples Reveals an Inverse Association between TMPRSS2:ERG Fusion Status and Immune Cell Infiltration.

Rao SR. et al, (2020), J Mol Diagn, 22, 652 - 669

The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial Cells.

Hu Z. et al, (2020), Cancer Cell, 37, 226 - 242.e7

TET2 drives 5hmc marking ofGATA6and epigenetically defines pancreatic ductal adenocarcinoma transcriptional subtypes

Eyres M. et al, (2020)

Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8+ Tumor-Infiltrating T Lymphocyte Responses.

Abd Hamid M. et al, (2019), Cancer Immunol Res, 7, 1293 - 1306

Comprehensive Analysis of Key Immune Checkpoint Receptors on Tumor-Infiltrating T Cells From Multiple Types of Cancer.

Li X. et al, (2019), Front Oncol, 9

Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.

Alton EWFW. et al, (2017), Thorax, 72, 137 - 147

Transgene sequences free of CG dinucleotides lead to high level, long-term expression in the lung independent of plasmid backbone design.

Bazzani RP. et al, (2016), Biomaterials, 93, 20 - 26

andomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis

Alton EWFW. et al, (2016)

Preparation for a First-in-Man Lentivirus Trial in Cystic Fibrosis Patients

Griesenbach U. et al, (2016), MOLECULAR THERAPY, 24, S214 - S214

Phase I/IIa Safety and Efficacy Study of Nebulized Liposome-mediated Gene Therapy for Cystic Fibrosis Supports a Multidose Trial.

Alton EWFW. et al, (2015), Am J Respir Crit Care Med, 192, 1389 - 1392

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial.

Alton EWFW. et al, (2015), Lancet Respir Med, 3, 684 - 691

Load More

1
2
3
4
5